4.7 Review

Formulation of Neulasta® (pegfilgrastim)

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 60, 期 1, 页码 50-58

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2007.04.017

关键词

r-metHuG-CSF; Neulasta (R) (pegfilgrastim); formulation; PEGylation

向作者/读者索取更多资源

Neulasta (R) (pegfilgrastim) is a PEGylated version of its parent molecule NEUPOGEN (R)) (Filgrastim). This work describes the formulation development for Neulasta (R) (pegfilgrastim), and the analytical techniques used to monitor degradation during these studies. Stability was assessed as a function of pH, protein concentration, buffer type, tonicity modifiers and surfactant concentration under both accelerated conditions and quiescent long-term storage. The stability of Neulasta (R) (pegfilgrastim) to agitation and successive freeze-thaw cycles was also assessed. Neulasta (R) (pegfilgrastim), at a protein concentration of 10 mg/mL formulated in 10 mM acetate, pH 4.0 with 5% sorbitol and 0.004% polysorbate 20, is stable for two years stored at 2-8 degrees C. (c) 2007 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据